CHRS 净利润历史(2016–2025)
Coherus Oncology, Inc. (CHRS) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
$168.0MFY2025 · FY2016 以来:-$127.3M → $168.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $168.0M | +489.4% |
| FY2024 | $28.5M | +112.0% |
| FY2023 | -$237.9M | +18.5% |
| FY2022 | -$291.8M | -1.6% |
| FY2021 | -$287.1M | -317.1% |
| FY2020 | $132.2M | +47.2% |
| FY2019 | $89.8M | +142.9% |
| FY2018 | -$209.3M | +12.1% |
| FY2017 | -$238.2M | -87.0% |
| FY2016 | -$127.3M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议